Showing results (141-150 of 969) with videos related to
Sort By:
Pageof 97
Haematologica|July 23, 2026
Relapse risk and survival benchmarks for non-transplanted acute myeloid leukemia patients in first complete remissionEitan Kugler, Farhad Ravandi, Alex Bazinet, et al.The Oncologist|August 26, 2015
Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic ImplicationsAziz Nazha, Joseph D Khoury, Raajit K Rampal, et al.Frontiers in Oncology|November 30, 2020
Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future DirectionsBachar Samra, Marina Konopleva, Alessandro Isidori, et al.American Journal of Hematology|September 2, 2022
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patientsGautam Borthakur, Farhad Ravandi, Keyur Patel, et al.American Journal of Hematology|July 21, 2018
Sorafenib Combined with 5-azacytidine in Older Patients with Untreated FLT3-ITD Mutated Acute Myeloid LeukemiaMaro Ohanian, Guillermo Garcia-Manero, Mark Levis, et al.Frontiers in Oncology|November 16, 2020
Emergence of BCR-ABL1 Fusion in AML Post-FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance - A Case SeriesAhmad S Alotaibi, Musa Yilmaz, Sanam Loghavi, et al.Clinical Lymphoma, Myeloma & Leukemia|January 28, 2014
Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogeneticsAziz Nazha, Hagop M Kantarjian, Vijaya R Bhatt, et al.Blood Cancer Journal|September 11, 2023
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitorsNicholas J Short, Daniel Nguyen, Farhad RavandiHematology/Oncology Clinics of North America|September 23, 2006
Monoclonal antibody therapy for hairy cell leukemiaDeborah A Thomas, Farhad Ravandi, Hagop KantarjianHaematologica|May 4, 2023
Maintenance therapy in acute myeloid leukemia: advances and controversiesJayastu Senapati, Tapan M Kadia, Farhad RavandiPageof 97